blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1001795

EP1001795 - VASOPROTECTIVE RECOMBINANT ADENOVIRUS VECTOR CONTAINING A HUMAN TFPI GENE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.02.2006
Database last updated on 28.09.2024
Most recent event   Tooltip10.02.2006Application deemed to be withdrawnpublished on 29.03.2006  [2006/13]
Applicant(s)For all designated states
Texas Heart Institute
Texas Medical Center MC-1268, P.O. Box 20345
Houston, TX 77225-0345 / US
[2000/21]
Inventor(s)01 / ZOLDHELYI, Pierre
4412 Jane Street
Bellaire, TX 77410 / US
02 / WILLERSON, James, T.
3314 Georgetown Road
Houston, TX 77005 / US
[2000/21]
Representative(s)Wise, Stephen James, et al
Murgitroyd & Company
165-169 Scotland Street
Glasgow, G5 8PL / GB
[N/P]
Former [2000/21]Wise, Stephen James, et al
c/o RAWORTH, MOSS & COOK 36 Sydenham Road
Croydon, Surrey CR0 2EF / GB
Application number, filing date98930076.905.06.1998
[2000/21]
WO1998US11706
Priority number, dateUS19970051887P08.07.1997         Original published format: US 51887 P
US1998001336626.01.1998         Original published format: US 13366
[2000/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9902171
Date:21.01.1999
Language:EN
[1999/03]
Type: A1 Application with search report 
No.:EP1001795
Date:24.05.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 21.01.1999 takes the place of the publication of the European patent application.
[2000/21]
Search report(s)International search report - published on:US21.01.1999
(Supplementary) European search report - dispatched on:EP21.03.2001
ClassificationIPC:A61K35/76, A61K48/00, C12N15/63, C12N15/64, C12N15/86
[2000/21]
CPC:
C07K14/8114 (EP,US); A61P7/02 (EP); A61P9/10 (EP);
A61K38/00 (EP,US); A61K48/00 (EP,US); C12N2799/022 (EP,US)
Designated contracting statesCH,   DE,   ES,   FR,   GB,   IT,   LI [2000/21]
TitleGerman:REKOMBINANTER, GEFÄSSSCHONENDER ADENOVIRUS-VEKTOR, DER EIN TFPI-GEN ENTHÄLT[2000/21]
English:VASOPROTECTIVE RECOMBINANT ADENOVIRUS VECTOR CONTAINING A HUMAN TFPI GENE[2000/21]
French:VECTEUR ADENOVIRAL RECOMBINANT VASOPROTECTEUR CONTENANT UN GENE TFPI HUMAIN[2000/21]
Entry into regional phase04.02.2000National basic fee paid 
04.02.2000Search fee paid 
04.02.2000Designation fee(s) paid 
04.02.2000Examination fee paid 
Examination procedure02.02.1999Request for preliminary examination filed
International Preliminary Examining Authority: US
04.02.2000Examination requested  [2000/21]
12.12.2002Despatch of a communication from the examining division (Time limit: M04)
31.03.2003Reply to a communication from the examining division
16.07.2003Despatch of a communication from the examining division (Time limit: M06)
21.01.2004Reply to a communication from the examining division
11.05.2005Communication of intention to grant the patent
22.09.2005Application deemed to be withdrawn, date of legal effect  [2006/13]
26.10.2005Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2006/13]
Fees paidRenewal fee
27.06.2000Renewal fee patent year 03
30.05.2001Renewal fee patent year 04
22.04.2002Renewal fee patent year 05
27.06.2003Renewal fee patent year 06
26.06.2004Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
30.06.200508   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9604378  (CHIRON CORP [US]);
 [Y]US5589363  (ROY SOUMITRA [US], et al);
 [Y]WO9720939  (GENENTECH INC [US]);
International search[Y]JPH09124506  (CHEMO SERO THERAPEUT RES INST);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.